Key players of neuroendocrine differentiation in prostate cancer

Affiliations

¹ Oncology Unit, Macerata Hospital, Macerata, Italy.
² Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.
³ Direzione Area Vasta 3-ASUR, Marche, Italy.

Editorial

Matteo Santoni et al. Ann Transl Med. 2019 Jul.

. 2019 Jul;7(Suppl 3):S112.

doi: 10.21037/atm.2019.05.18.

¹ Oncology Unit, Macerata Hospital, Macerata, Italy.
² Medical Oncology Division of Urogenital and Head and Neck Tumours, IEO, European Institute of Oncology IRCCS, Milan, Italy.
³ Direzione Area Vasta 3-ASUR, Marche, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer.
Reina-Campos M, Linares JF, Duran A, Cordes T, L'Hermitte A, Badur MG, Bhangoo MS, Thorson PK, Richards A, Rooslid T, Garcia-Olmo DC, Nam-Cha SY, Salinas-Sanchez AS, Eng K, Beltran H, Scott DA, Metallo CM, Moscat J, Diaz-Meco MT. Reina-Campos M, et al. Cancer Cell. 2019 Mar 18;35(3):385-400.e9. doi: 10.1016/j.ccell.2019.01.018. Epub 2019 Feb 28. Cancer Cell. 2019. PMID: 30827887 Free PMC article.

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.
Santoni M, Cimadamore A, Massari F, Piva F, Aurilio G, Martignetti A, Scarpelli M, Di Nunno V, Gatto L, Battelli N, Cheng L, Lopez-Beltran A, Montironi R. Santoni M, et al. Cancers (Basel). 2019 Aug 22;11(9):1225. doi: 10.3390/cancers11091225. Cancers (Basel). 2019. PMID: 31443386 Free PMC article. Review.

1. Reina-Campos M, Linares JF, Duran A, et al. Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer. Cancer Cell 2019;35:385-400.e9. 10.1016/j.ccell.2019.01.018 - DOI - PMC - PubMed
1. Montironi R, Santoni M, Lopez-Beltran A, et al. Morphologic and molecular backgrounds for personalized management of genito-urinary cancers: an overview. Curr Drug Targets 2015;16:96-102. 10.2174/1389450115666141202113805 - DOI - PubMed
1. Santoni M, Scarpelli M, Mazzucchelli R, et al. Current Histopathologic and Molecular Characterizations of Prostate cancer: Towards Individualized Prognosis and Therapies. Eur Urol 2016;69:186-90. 10.1016/j.eururo.2015.05.041 - DOI - PubMed
1. Ciccarese C, Santoni M, Massari F, et al. Present and future of personalized medicine in adult genitourinary tumors. Future Oncol 2015;11:1381-8. 10.2217/fon.15.30 - DOI - PubMed
1. Ciccarese C, Santoni M, Brunelli M, et al. AR-V7 and prostate cancer: The watershed for treatment selection? Cancer Treat Rev 2016;43:27-35. 10.1016/j.ctrv.2015.12.003 - DOI - PubMed